Weiss Multi Strategy Advisers LLC Aldeyra Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

$0
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.11 - $8.16 $38,352 - $51,220	-6,277 Reduced 12.55%	43,723 $292,000
Q2 2023 Aug 14, 2023	SELL	$7.11 - $11.89 $63,762 - $106,629	-8,968 Reduced 15.21%	50,000 $420,000
Q1 2023 May 15, 2023	SELL	$5.77 - $9.93 $82,095 - $141,284	-14,228 Reduced 19.44%	58,968 $586,000
Q4 2022 Feb 14, 2023	SELL	$5.08 - $7.09 $22,839 - $31,876	-4,496 Reduced 5.79%	73,196 $509,000
Q3 2022 Nov 14, 2022	SELL	$3.8 - $7.74 $9,663 - $19,682	-2,543 Reduced 3.17%	77,692 $415,000
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $120,928 - $241,360	-49,765 Reduced 38.28%	80,235 $320,000
Q1 2022 May 16, 2022	BUY	$3.25 - $5.17 $8,297 - $13,199	2,553 Added 2.0%	130,000 $578,000
Q4 2021 Feb 14, 2022	SELL	$3.5 - $9.63 $69,972 - $192,522	-19,992 Reduced 13.56%	127,447 $510,000
Q3 2021 Nov 15, 2021	BUY	$7.94 - $11.31 $51,887 - $73,910	6,535 Added 4.64%	147,439 $1.3 Million
Q2 2021 Aug 16, 2021	SELL	$10.44 - $14.85 $112,532 - $160,068	-10,779 Reduced 7.11%	140,904 $1.6 Million
Q1 2021 May 14, 2021	BUY	$6.53 - $14.42 $256,178 - $565,711	39,231 Added 34.89%	151,683 $1.8 Million
Q4 2020 Feb 16, 2021	SELL	$6.31 - $8.13 $28,666 - $36,934	-4,543 Reduced 3.88%	112,452 $771,000
Q3 2020 Nov 16, 2020	BUY	$4.0 - $7.53 $5,204 - $9,796	1,301 Added 1.12%	116,995 $867,000
Q2 2020 Aug 14, 2020	SELL	$1.97 - $5.05 $62,179 - $159,393	-31,563 Reduced 21.43%	115,694 $482,000
Q1 2020 May 15, 2020	SELL	$1.62 - $6.4 $85,443 - $337,555	-52,743 Reduced 26.37%	147,257 $364,000
Q1 2019 May 15, 2019	BUY	$7.14 - $9.85 $107,100 - $147,750	15,000 Added 8.11%	200,000 $1.81 Million
Q3 2018 Nov 14, 2018	BUY	$6.8 - $14.35 $984,640 - $2.08 Million	144,800 Added 360.2%	185,000 $2.55 Million
Q2 2018 Aug 14, 2018	SELL	$6.95 - $9.18 $50,040 - $66,096	-7,200 Reduced 15.19%	40,200 $320,000
Q1 2018 May 15, 2018	SELL	$6.55 - $8.9 $17,030 - $23,140	-2,600 Reduced 5.2%	47,400 $356,000
Q3 2017 Nov 14, 2017	BUY	$3.9 - $10.8 $195,000 - $540,000	50,000	50,000 $360,000

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36.4M

Call Options Held

196K

Put Options Held

142K

Perceptive Advisors LLC New York, NY

9.28M
Shares

$44.4 Million
1.31% of portfolio
Knoll Capital Management, LLC Miami, FL

5.48M
Shares

$26.2 Million
14.56% of portfolio
Vanguard Group Inc Valley Forge, PA

3.76M
Shares

$18 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.62M
Shares

$17.3 Million
0.0% of portfolio
Kennedy Capital Management, Inc. St Louis, MO

1.88M
Shares

$9.01 Million
0.24% of portfolio

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $279M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Account